360 related articles for article (PubMed ID: 23584542)
1. Synthesis and evaluation of novel marine bromopyrrole alkaloid-based hybrids as anticancer agents.
Rane RA; Sahu NU; Gutte SD; Mahajan AA; Shah CP; Bangalore P
Eur J Med Chem; 2013 May; 63():793-9. PubMed ID: 23584542
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of Novel Hybrids Inspired from Bromopyrrole Alkaloids Inhibiting MMP-2 and -12 as Antineoplastic Agents.
Rane RA; Naphade SS; Bangalore PK; Palkar MB; Patel HM; Shaikh MS; Alwan WS; Karpoormath R
Chem Biol Drug Des; 2015 Aug; 86(2):210-22. PubMed ID: 25418204
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and anti-proliferative activity of fluoro-substituted chalcones.
Burmaoglu S; Algul O; Anıl DA; Gobek A; Duran GG; Ersan RH; Duran N
Bioorg Med Chem Lett; 2016 Jul; 26(13):3172-3176. PubMed ID: 27217001
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of novel antineoplastic agents inspired from marine bromopyrrole alkaloids.
Rane RA; Bangalore PK; Naphade SS; Patel HM; Palkar MB; Karpoormath R
Anticancer Agents Med Chem; 2015; 15(5):548-54. PubMed ID: 25495466
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of Flavone Derivatives via
Zhang N; Yang J; Li K; Luo J; Yang S; Song JR; Chen C; Pan WD
Molecules; 2019 Jul; 24(15):. PubMed ID: 31357486
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of novel flavone/triazole/benzimidazole hybrids and flavone/isoxazole-annulated heterocycles as antiproliferative and antimycobacterial agents.
Rao YJ; Sowjanya T; Thirupathi G; Murthy NYS; Kotapalli SS
Mol Divers; 2018 Nov; 22(4):803-814. PubMed ID: 29869169
[TBL] [Abstract][Full Text] [Related]
7. 1,2,3-Triazole tethered β-lactam-chalcone bifunctional hybrids: synthesis and anticancer evaluation.
Singh P; Raj R; Kumar V; Mahajan MP; Bedi PM; Kaur T; Saxena AK
Eur J Med Chem; 2012 Jan; 47(1):594-600. PubMed ID: 22071256
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of 3,5-diaryl isoxazoline/isoxazole linked 2,3-dihydroquinazolinone hybrids as anticancer agents.
Kamal A; Bharathi EV; Reddy JS; Ramaiah MJ; Dastagiri D; Reddy MK; Viswanath A; Reddy TL; Shaik TB; Pushpavalli SN; Bhadra MP
Eur J Med Chem; 2011 Feb; 46(2):691-703. PubMed ID: 21194809
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of novel pyrimidine-benzimidazol hybrids as potential anticancer agents.
Shao KP; Zhang XY; Chen PJ; Xue DQ; He P; Ma LY; Zheng JX; Zhang QR; Liu HM
Bioorg Med Chem Lett; 2014 Aug; 24(16):3877-81. PubMed ID: 25001482
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of novel ligustrazine-chalcone derivatives as potential anti-triple negative breast cancer agents.
Luo Y; Wu W; Zha D; Zhou W; Wang C; Huang J; Chen S; Yu L; Li Y; Huang Q; Zhang J; Zhang C
Bioorg Med Chem Lett; 2021 Sep; 47():128230. PubMed ID: 34186178
[TBL] [Abstract][Full Text] [Related]
11. Biological evaluation of indolizine-chalcone hybrids as new anticancer agents.
Park S; Kim EH; Kim J; Kim SH; Kim I
Eur J Med Chem; 2018 Jan; 144():435-443. PubMed ID: 29288944
[TBL] [Abstract][Full Text] [Related]
12. Syntheses of novel β-carboline derivatives and the activities against five tumor-cell lines.
Bai B; Li XY; Liu L; Li Y; Zhu HJ
Bioorg Med Chem Lett; 2014 Jan; 24(1):96-8. PubMed ID: 24345445
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of novel 1,2,3-triazole/isoxazole functionalized 2H-Chromene derivatives and their cytotoxic activity.
Ratnakar Reddy K; Sambasiva Rao P; Jitender Dev G; Poornachandra Y; Ganesh Kumar C; Shanthan Rao P; Narsaiah B
Bioorg Med Chem Lett; 2014 Apr; 24(7):1661-3. PubMed ID: 24641975
[TBL] [Abstract][Full Text] [Related]
14. Moxifloxacin-isatin Hybrids Tethered by 1,2,3-triazole and their Anticancer Activities.
Yang M; Liu H; Zhang Y; Wang X; Xu Z
Curr Top Med Chem; 2020; 20(16):1461-1467. PubMed ID: 31994464
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of novel isoxazolyl chalcones as potential anticancer agents.
Wan M; Xu L; Hua L; Li A; Li S; Lu W; Pang Y; Cao C; Liu X; Jiao P
Bioorg Chem; 2014 Jun; 54():38-43. PubMed ID: 24747188
[TBL] [Abstract][Full Text] [Related]
16. Antiproliferative novel isoxazoles: modeling, virtual screening, synthesis, and bioactivity evaluation.
Tzanetou E; Liekens S; Kasiotis KM; Melagraki G; Afantitis A; Fokialakis N; Haroutounian SA
Eur J Med Chem; 2014 Jun; 81():139-49. PubMed ID: 24836066
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and cellular bioactivities of novel isoxazole derivatives incorporating an arylpiperazine moiety as anticancer agents.
Çalışkan B; Sinoplu E; İbiş K; Akhan Güzelcan E; Çetin Atalay R; Banoglu E
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1352-1361. PubMed ID: 30251900
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and anticancer activity of novel spiro-isoxazoline and spiro-isoxazolidine derivatives of α-santonin.
Khazir J; Singh PP; Reddy DM; Hyder I; Shafi S; Sawant SD; Chashoo G; Mahajan A; Alam MS; Saxena AK; Arvinda S; Gupta BD; Kumar HM
Eur J Med Chem; 2013 May; 63():279-89. PubMed ID: 23501113
[TBL] [Abstract][Full Text] [Related]
19. Phenylpropiophenone derivatives as potential anticancer agents: synthesis, biological evaluation and quantitative structure-activity relationship study.
Ivković BM; Nikolic K; Ilić BB; Žižak ŽS; Novaković RB; Čudina OA; Vladimirov SM
Eur J Med Chem; 2013 May; 63():239-55. PubMed ID: 23501110
[TBL] [Abstract][Full Text] [Related]
20. Efficient access to domain-integrated estradiol-flavone hybrids via the corresponding chalcones and their in vitro anticancer potential.
Molnár B; Gopisetty MK; Nagy FI; Adamecz DI; Kása Z; Kiricsi M; Frank É
Steroids; 2022 Nov; 187():109099. PubMed ID: 35970223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]